Apple
AAPL
Oracle
ORCL
NVIDIA
NVDA
Microsoft
MSFT
Adobe
ADBE
US Stock MarketDetailed Quotes
TSOI THERAPEUTIC SOLUTIONS INTL INC
- 0.000300
- 0.0000000.00%
15min DelayTrading Dec 24 13:00 ET
1.16MMarket Cap-0.30P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.000300Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)3.86BShares0.00190052wk High0.00P/B1.16MFloat Cap0.00020052wk Low--Dividend TTM3.86BShs Float0.134500Historical High--Div YieldTTM0.00%Amplitude0.000200Historical Low--Avg Price1Lot Size
THERAPEUTIC SOLUTIONS INTL INC Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -23.56%19.67K | -23.96%20.01K | -5.66%21.81K | -52.12%98.99K | 177.81%23.83K | -65.48%25.73K | -32.11%26.31K | -72.76%23.12K | 41.66%206.77K | -80.57%8.58K |
| Operating revenue | -23.56%19.67K | -23.96%20.01K | -5.66%21.81K | -52.12%98.99K | 177.81%23.83K | -65.48%25.73K | -32.11%26.31K | -72.76%23.12K | 41.66%206.77K | -80.57%8.58K |
| Cost of revenue | -37.48%4.41K | -37.12%6.73K | -11.53%7.49K | -53.72%36.77K | -77.06%10.55K | -19.77%7.05K | 22.85%10.7K | -46.88%8.47K | 86.72%79.44K | 207.79%46K |
| Gross profit | -18.31%15.26K | -14.93%13.28K | -2.27%14.32K | -51.13%62.23K | 135.49%13.28K | -71.59%18.68K | -48.04%15.61K | -78.75%14.66K | 23.13%127.33K | -228.10%-37.42K |
| Operating expense | 314.86%1.97M | -25.23%417.32K | 54.67%687.57K | -39.86%2.05M | -38.08%570.05K | -39.36%476.01K | -49.51%558.12K | -25.37%444.52K | 41.49%3.41M | -2.80%920.65K |
| Selling and administrative expenses | 498.75%1.96M | 14.35%399.75K | 60.53%628.95K | -23.87%1.49M | -35.02%419.55K | -35.84%327.13K | -31.12%349.58K | 34.41%391.8K | 21.18%1.95M | 92.13%645.65K |
| -General and administrative expense | 498.75%1.96M | 14.35%399.75K | 60.53%628.95K | -23.87%1.49M | -35.02%419.55K | -35.84%327.13K | -31.12%349.58K | 34.41%391.8K | 21.18%1.95M | 92.13%645.65K |
| Research and development costs | -89.22%16.05K | -91.57%17.57K | 11.16%58.61K | -61.39%560.65K | -45.27%150.51K | -45.88%148.88K | -65.12%208.54K | -82.66%52.73K | 82.72%1.45M | -55.00%275.01K |
| Operating profit | -328.47%-1.96M | 25.52%-404.04K | -56.62%-673.24K | 39.43%-1.99M | 41.89%-556.77K | 36.41%-457.34K | 49.55%-542.51K | 18.38%-429.87K | -42.31%-3.28M | -4.37%-958.08K |
| Net non-operating interest income expense | -28.03%-106.35K | 39.46%-74.01K | 26.78%-89.19K | 34.49%-423.27K | 27.90%-96.13K | 50.37%-83.06K | 37.43%-122.26K | 18.79%-121.81K | -5.61%-646.09K | 37.22%-133.33K |
| Non-operating interest expense | 28.03%106.35K | -39.46%74.01K | -26.78%89.19K | -34.49%423.27K | -27.90%96.13K | -50.37%83.06K | -37.43%122.26K | -18.79%121.81K | 5.61%646.09K | -37.22%133.33K |
| Other net income (expense) | 148.74%30.44K | -85.83%14.49K | 92.99%-1.84K | 282.19%187.29K | 463.93%173.65K | -5.74%-62.46K | 27.86%102.31K | -134.58%-26.2K | 210.11%49.01K | 75.06%-47.71K |
| Gain on sale of security | 148.74%30.44K | -13.55%14.49K | 92.99%-1.84K | -88.01%19.15K | 44.68%91.05K | -5.74%-62.46K | -79.05%16.77K | -134.58%-26.2K | 458.72%159.65K | 132.89%62.93K |
| Special income (charges) | --0 | --0 | ---- | --168.15K | --82.6K | --0 | --85.55K | ---- | --0 | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---168.15K | ---82.6K | ---- | ---85.55K | ---- | ---- | ---- |
| Other non- operating income (expenses) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---110.64K | ---- |
| Income before tax | -237.63%-2.04M | 17.58%-463.56K | -32.25%-764.27K | 42.67%-2.22M | 57.93%-479.26K | 36.25%-602.86K | 52.76%-562.46K | 3.83%-577.88K | -30.93%-3.88M | 13.81%-1.14M |
| Income tax | 0 | 0.00%800 | 0 | 40.63%2.25K | 81.25%1.45K | 0 | 800 | 0 | 100.00%1.6K | 0.00%800 |
| Net income | -237.63%-2.04M | 17.56%-464.36K | -32.25%-764.27K | 42.63%-2.22M | 57.83%-480.71K | 36.30%-602.86K | 52.70%-563.26K | 3.83%-577.88K | -30.95%-3.88M | 13.80%-1.14M |
| Net income continuous Operations | -237.63%-2.04M | 17.56%-464.36K | -32.25%-764.27K | 42.63%-2.22M | 57.83%-480.71K | 36.30%-602.86K | 52.70%-563.26K | 3.83%-577.88K | -30.95%-3.88M | 13.80%-1.14M |
| Minority interest income | -125,867.28%-1.03M | -8,581.19%-74.31K | -179.13K | 14.35%-54.89K | 16.96%-53.21K | -816 | -856 | 0 | -64.08K | -64.08K |
| Net income attributable to the parent company | -67.35%-1.01M | 30.65%-390.05K | -1.26%-585.14K | 43.11%-2.17M | 60.26%-427.49K | 36.39%-602.04K | 52.77%-562.4K | 3.83%-577.88K | -28.79%-3.81M | 18.65%-1.08M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -67.35%-1.01M | 30.65%-390.05K | -1.26%-585.14K | 43.11%-2.17M | 60.26%-427.49K | 36.39%-602.04K | 52.77%-562.4K | 3.83%-577.88K | -28.79%-3.81M | 18.65%-1.08M |
| Basic earnings per share | -12.02%-0.0002 | 54.50%-0.0001 | 31.16%-0.0001 | 54.61%-0.0007 | 75.36%-0.0001 | 50.41%-0.0002 | 59.70%-0.0002 | 14.34%-0.0002 | -15.28%-0.0015 | 28.74%-0.0004 |
| Diluted earnings per share | -12.02%-0.0002 | 54.50%-0.0001 | 31.16%-0.0001 | 54.61%-0.0007 | 75.36%-0.0001 | 50.41%-0.0002 | 59.70%-0.0002 | 14.34%-0.0002 | -15.28%-0.0015 | 28.74%-0.0004 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
